CIBC World Market’s Ginkgo Bioworks DNA Stock Holding History

CIBC World Market’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,065	Closed	-$632K	–	1270
2022 Q3	$632K	Buy	+5,065	New	+$604K	﹤0.01%	826

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

CIBC World Market's DNA Position: Q4 2022 in Review

CIBC World Market sold out of Ginkgo Bioworks (DNA) in Q4 2022, closing a stake of 5,065 shares — an estimated $632K sold.

CIBC World Market first reported a position in DNA in Q3 2022 and held it in 1 quarter. The position peaked at $632K in Q3 2022. 320 funds tracked by Wall St. Rank hold DNA as of Q4 2022.

CIBC World Market reported no remaining Ginkgo Bioworks position as of Q4 2022 after selling out during the quarter.
CIBC World Market sold 5,065 Ginkgo Bioworks shares in Q4 2022, an estimated $632K.
CIBC World Market first reported a position in Ginkgo Bioworks in Q3 2022 and held it in 1 quarter.
CIBC World Market's Ginkgo Bioworks position peaked at $632K in Q3 2022.
320 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2022.

Based on CIBC World Market's 13F filing for Q4 2022, filed 13 Feb 2023.